Francis Patrick Ostronic, Director at Cyclo Therapeutics, Inc. (CYTH), bought 5,000 shares at $1.76 ($9K) on 2022-09-21, disclosed to the SEC on 2022-09-22.
Open-market purchase of $9k CYTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CYTH | BUY | 2022-01-24 | $8K | — | Filing → |
| CYTH | BUY | 2022-01-19 | $5K | — | Filing → |
| CYTH | BUY | 2022-01-18 | $7K | — | Filing → |